Catalyst Clinical Research Acquires Aptus Clinical
May 4, 2022
Catalyst Clinical Research, a portfolio company of NovaQuest Capital Management, has acquired U.K.-based Aptus Clinical to accelerate Catalyst's European expansion and broaden its oncology and early-phase clinical services. The deal creates a multi-region CRO operating across North America and Europe, increases Catalyst's patient reach by nearly 600 and lifts combined headcount to more than 800.
- Targets
- Aptus Clinical
- Platforms
- Catalyst Clinical Research
- Industry
- Healthcare Services
- Location
- Cheshire, United Kingdom
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Worldwide Clinical Trials Acquires Catalyst Clinical Research
February 17, 2026
Healthcare Services
Worldwide Clinical Trials completed its acquisition of oncology CRO Catalyst Clinical Research, expanding Worldwide’s oncology capabilities, biometrics, and functional service provider (FSP) offerings. The combined organization will operate with a workforce of approximately 4,400 employees across more than 70 countries, and financial terms were not disclosed.
-
Catalyst Clinical Research Acquires Genpro Research
July 20, 2023
Healthcare Services
Catalyst Clinical Research, a Wilmington, North Carolina-based CRO and portfolio company of QHP Capital, has acquired Genpro Research, a Massachusetts-based clinical research organization with staff in the US, India, and Ireland. The deal adds more than 120 India-based team members and strengthens Catalyst's capabilities in biometrics/biostatistics, medical writing, real-world evidence (RWE)/HEOR, and AI-enabled automation.
-
Apax Development Acquires Majority Stake in Porsolt
February 21, 2023
Biotechnology
Apax Development, a European private equity firm, has acquired a majority stake in Porsolt SAS, a French preclinical Contract Research Organization (CRO). The investment will support Porsolt's plans to expand services, accelerate hiring (targeting ~40% headcount growth), pursue bolt-on acquisitions in Europe and the US, and extend its global footprint.
-
Catalyst Clinical Research Merges with Ce3, Inc.
August 5, 2020
Healthcare Services
Catalyst Clinical Research, a NovaQuest-backed CRO headquartered in Wilmington, North Carolina, has merged with Ce3, Inc., an early-phase oncology-focused CRO based in Clinton, Connecticut. The transaction combines Ce3's 15+ years of oncology expertise with Catalyst's broader clinical development and technology capabilities to create a next-generation oncology-focused CRO (add-on to Catalyst's NovaQuest-backed platform).
-
3 Rivers Capital Acquires Aptus Group USA
December 20, 2019
Infrastructure
3 Rivers Capital, a lower middle-market private equity firm, has acquired Aptus Group USA, a Charlotte-based provider of bridge-attached utility repair and maintenance services. The founder, Scott T. Dill, remains CEO as 3RC partners with Aptus to expand its geographic footprint beyond the eastern U.S. and accelerate strategic growth.
-
Thoma Bravo Acquires Majority Interest in Apttus
September 4, 2018
Software
Thoma Bravo signed a definitive agreement to acquire a majority interest in Apttus, a San Mateo–based provider of Quote-to-Cash, Contract Lifecycle Management and Middle Office software. The deal (expected to close in early October 2018) will pair Apttus’ enterprise revenue-management platform with Thoma Bravo’s software operating experience to accelerate growth and scale; financial and legal advisors and financing partners were disclosed but financial terms were not.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.